|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
TISSUE-SPECIFIC STEM CELLS |
aDepartment of Clinical Renal Regeneration, Graduate School of Medicine, University of Tokyo, Bunkyo-ku, Tokyo, Japan;
bDepartment of Internal Medicine, Division of Nephrology and Endocrinology, University of Tokyo, Bunkyo-ku, Tokyo, Japan;
cDepartment of Urology, University of Tokyo, Bunkyo-ku, Tokyo, Japan;
dDepartment of Physiology, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan;
eRenal Section, Evans Biomedical Research Center, Boston University Medical Center, Boston, Massachusetts, USA
Key Words. Stem cell • Side population • Transcription regulation • Chronic renal failure • Anti-glomerular basement membrane disease
Correspondence: Keiichi Hishikawa, M.D., Ph.D., Department of Internal Medicine, Division of Nephrology and Endocrinology, The University of Tokyo Hospital, Hongo 7-3-1, Bunkyo-ku, Tokyo 113-865, Japan. Telephone: +81-3-3815-5411, ext. 35725; Fax: +81-3-5800-9738; e-mail: hishikawa-tky{at}umin.ac.jp
Received on January 23, 2007;
accepted for publication on July 9, 2007.
Disclosure of potential conflicts of interest is found at the end of this article.
First published online in STEM CELLS EXPRESS July 19, 2007.
Bone morphogenic protein (BMP)-7 is expressed in the adult kidney and reverses chronic renal injury when given exogenously. Here, we report that a histone deacetylase inhibitor, trichostatin A (TSA), attenuates chronic renal injury, in part, by augmenting the expression of BMP-7 in kidney side population (SP) cells. We induced accelerated nephrotoxic serum nephritis (NTN) in C57BL/6 mice and treated them with TSA for 3 weeks. Compared with vehicle-treated NTN mice, treatment with TSA prevented the progression of proteinuria, glomerulosclerosis, interstitial fibrosis, and loss of kidney SP cells. Basal gene expression of renoprotective factors such as BMP-7, vascular endothelial growth factor, and hepatocyte growth factor was significantly higher in kidney SP cells as compared with non-SP cells. Treatment with TSA significantly upregulated the expression of BMP-7 in SP cells but not in non-SP cells. Moreover, initiation of treatment with TSA after 3 weeks of NTN (for 3 weeks, until 6 weeks) partially but significantly reversed renal dysfunction. Our results indicate an important role of SP cells in the kidney as one of the possible generator cells of BMP-7 and TSA as a stimulator of the cells in reversing chronic renal disease.
This article has been cited by other articles:
![]() |
S. R. Singh and S. X. Hou Multipotent stem cells in the Malpighian tubules of adult Drosophila melanogaster J. Exp. Biol., February 1, 2009; 212(3): 413 - 423. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| STEM CELLS | THE ONCOLOGIST | CME | ALPHAMED PRESS JOURNALS |